Previous close | 37.38 |
Open | 37.38 |
Bid | 45.20 |
Ask | 53.90 |
Strike | 200.00 |
Expiry date | 2026-01-16 |
Day's range | 37.38 - 37.38 |
Contract range | N/A |
Volume | |
Open interest | 10 |
Biogen ( NASDAQ:BIIB ) First Quarter 2024 Results Key Financial Results Revenue: US$2.29b (down 7.0% from 1Q 2023). Net...
It's been a good week for Biogen Inc. ( NASDAQ:BIIB ) shareholders, because the company has just released its latest...
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.